Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study

NCT04669990 · clinicaltrials.gov ↗

UNKNOWN

Status

2000

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19

Interventions

DRUG: Remdesivir

Sponsor

Nepal Health Research Council